Pfizer seeks US emergency authorization for COVID-19 pill

Sumary of Pfizer seeks US emergency authorization for COVID-19 pill:

  • Pfizer’s CEO Albert Bourla said Tuesday that the pharmaceutical giant was seeking expedited authorization from the US Food and Drug Administraton (FDA) for its newly developed pill to fight COVID-19. The company said that the pill had been shown to reduce hospitalizations and deaths by 89% amongst newly-infected high risk patients.
  • “We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients.
  • ” Pfizer is seeking what is known as an emergency use authorization (EUA) on the basis of initial results from a clinical trial comprising hundreds of COVID-19 patients who were not hospitalized but considered at high risk of progression to severe disease.
  • Pfizer said that its pill, which is called Paxlovid, led to side effects in one out of five patients, but that they were mild.

Want to know more click here go to source.

From -


Site Language

Popular Posts


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.